Sampaziotis Fotios, Tysoe Olivia, Brevini Teresa, Vallier Ludovic
Wellcome Trust and MRC Cambridge Stem Cell Institute, Anne McLaren Laboratory for Regenerative Medicine, University of Cambridge, Cambridge, UK.
Department of Medicine, University of Cambridge, Cambridge, UK.
Methods Mol Biol. 2019;1981:373-382. doi: 10.1007/978-1-4939-9420-5_25.
Cholangiocytes play a crucial role in the pathophysiology of cholestasis. However, research on human cholangiocytes has been restricted by challenges in long-term propagation and large-scale expansion of primary biliary epithelium. The advent of organoid technology has overcome this limitation allowing long-term culture of a variety of epithelia from multiple organs. Here, we describe two methods for growing human cholangiocytes in organoid format. The first applies to the generation of intrahepatic bile ducts using human induced pluripotent stem cells using a protocol of differentiation that recapitulates physiological bile duct development. The second method allows the propagation of primary biliary epithelium from the extrahepatic ducts or gallbladder. Both protocols result in large numbers of cholangiocyte organoids expressing biliary markers and maintaining key cholangiocyte functions.
胆管细胞在胆汁淤积的病理生理学中起着关键作用。然而,对人类胆管细胞的研究受到原代胆管上皮细胞长期传代和大规模扩增挑战的限制。类器官技术的出现克服了这一限制,使得来自多个器官的多种上皮细胞能够长期培养。在此,我们描述两种以类器官形式培养人类胆管细胞的方法。第一种方法适用于使用人类诱导多能干细胞,通过模拟生理性胆管发育的分化方案来生成肝内胆管。第二种方法允许肝外胆管或胆囊的原代胆管上皮细胞进行扩增。这两种方案都能产生大量表达胆管标志物并维持关键胆管细胞功能的胆管细胞类器官。